Which of the following are arguments against direct-to-consumer pharmaceutical advertising (DTCPA)? Select all that apply.

A. Encourages overutilization of drugs
B. Strains the patient-provider relationship
C. Educates, empowers, and informs the public
D. Encourages patient compliance
E. Reduces underdiagnosis and undertreatment of some diseases



Answer :

Final answer:

DTCPA has drawbacks such as promoting overutilization of drugs, straining the patient-provider relationship, and potentially reducing underdiagnosis and undertreatment of diseases.


Explanation:

Arguments against direct-to-consumer pharmaceutical advertising (DTCPA) include:

  • Encourages overutilization of drugs: DTCPA can lead to patients requesting unnecessary medications.
  • Strains the patient-provider relationship: By influencing patients' demands, DTCPA can disrupt the trust and communication between patients and healthcare providers.
  • Reduces underdiagnosis and undertreatment of some diseases: DTCPA may prioritize expensive treatments over necessary preventive care or non-pharmacological interventions.

Learn more about Arguments against direct-to-consumer pharmaceutical advertising (DTCPA) here:

https://brainly.com/question/29530544